Bone quality in diabetes

Frontiers in Endocrinology

Volumn 4, Issue JUN, 2013, Pages

  Saito, Mitsuru ^a   Marumo, Keishi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Bone quality; Collagen cross links; Diabetes; Osteoporosis; Pentosidine

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; COLLAGEN; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; GLUCOSE; HYDROXYLYSINE; OSTEOCALCIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PENTOSIDINE; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; PROTEIN LYSINE 6 OXIDASE; PYRIDINOLINE; PYRIDOXAL; PYRIDOXAMINE; PYRIDOXINE; PYRROLIDINE DERIVATIVE; SCLEROSTIN;

BONE DENSITY; BONE MINERALIZATION; BONE STRENGTH; DIABETES MELLITUS; ENERGY ABSORPTION; ENZYME ACTIVITY; FEMUR; FRACTURE; HUMAN; JOINT STIFFNESS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOPOROSIS; OXIDATION; OXIDATIVE STRESS; PROTEIN CROSS LINKING; PROTEIN GLYCOSYLATION; REVIEW; YOUNG MODULUS;

EID: 84884201196     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00072     Document Type: Review

References (96)

1. Atsawasuwan, P., Mochida, Y., Parisuthiman, D., and Yamauchi, M. (2005). Expression of lysyl oxidase isoforms in MC3T3-E1 osteoblastic cells. Biochem. Biophys. Res. Commun. 327, 1042-1046. doi:10.1016/j.bbrc.2004.12.119
2. Bank, R. A., Beekman, B., Verzijl, N., de Roos, J. A., Sakkee, A. N., and TeKoppele, J. M. (1997). Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run. J. Chromatogr. B Biomed. Sci. Appl. 703, 37-44. doi:10.1016/S0378-4347 (97)00391-5
3. Bank, R. A., Robins, S. P., Wijmenga, C., Breslau-Siderius, L. J., Bardoel, A. F., van der Sluijs, H. A., et al. (1999). Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome. 17. Proc. Natl. Acad. Sci. U.S.A. 96, 1054- 1058. doi:10.1073/pnas.96.3.1054
4. Banse, X., Sims, T. J., and Bailey, A. J. (2002). Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. J. Bone Miner. Res. 17, 1621-1628. doi:10.1359/jbmr.2002.17.9.1621
5. Bird, T. A., and Levene, C. I. (1982). Lysyl oxidase: evidence that pyridoxal phosphate is a co-factor. Biochem. Biophys. Res. Commun. 108, 1172-1180. doi:10.1016/0006-291X(82)92124-6 CrossRef Full Text
6. Blouin, S., Thaler, H. W., Korninger, C., Schmid, R., Hofstaetter, J. G., Zoehrer, R., et al. (2009). Bone matrix quality and plasma homocysteine levels. Bone 44, 959- 964. doi:10.1016/j.bone.2008.12.023
7. Brady, J. D., and Robins, S. P. (2001). Structural characterization of pyrrolic cross-links in collagen using a biotinylated Ehrlich's reagent. J. Biol. Chem. 276, 18812- 18818. doi:10.1074/jbc.M009506200
8. Brennan, M. (1989). Changes in solubility, non-enzymatic glycation, and fluorescence of collagen in tail tendons from diabetic rats. J. Biol. Chem. 264, 20947- 20852.
9. Cortizo, A. M., Lettieri, M. G., Barrio, D. A., Mercer, N., Etcheverry, S. B., and McCarthy, A. D. (2003). Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK). Mol. Cell. Biochem. 250, 1-10. doi:10.1023/A:1024934008982
10. Cui, S., Xiong, F., Hong, Y., Jung, J. U., Li, X. S., Liu, J. Z., et al. (2011). APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner. J. Bone Miner. Res. 26, 1084-1098. doi:10.1002/jbmr.299
11. Dong, X. N., Qin, A., Xu, J., and Wang, X. (2011). In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption. Bone 49, 174-183. doi:10.1016/j.bone.2011.04.009
12. Ebesunun, M. O., and Obajobi, E. O. (2012). Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases. Pan. Afr. Med. J. 12, 48.
13. Eyre, D. R., Dickson, I. R., and Van Ness, K. (1988). Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem. J. 252, 495-500.
14. Eyre, D. R., Paz, A., and Gallop, P. M. (1984). Cross-linking in collagen and elastin. Annu. Rev. Biochem. 53, 717-748. doi:10.1146/annurev.bi.53.070184.003441
15. Feres-Filho, E. J., Choi, Y. J., Han, X., Takala, T. E., and Trackman, P. C. (1995). Pre- and post-translational regulation of lysyl oxidase by transforming growth factor -beta 1 in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 270, 30797-30803. doi:10.1074/jbc.270.51.30797
16. Feres-Filho, E. J., Menassa, G. B., and Trackman, P. C. (1996). Regulation of lysyl oxidase by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 271, 6411-6416. doi:10.1074/jbc.271.11.6411
17. Fujii, K., Kajiwara, T., and Kurosu H. (1979). Effect of vitamin B6 deficiency on the crosslink formation of collagen. FEBS Lett. 97, 193-195. doi:10.1016/0014-5793 (79)80082-4
18. Fujii, K., Kuboki, Y., and Sasaki, S. (1976). Aging of human bone and cartilage collagen: changes in the reducible cross-links and their precursors. Gerontology 22, 363-370. doi:10.1159/000212148
19. Garnero, P., Borel, O., Gineyts, E., Duboeuf, F., Solberg, H., Bouxsein, M. L., et al. (2006). Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone 38, 300-309. doi:10.1016/j.bone.2005.09.014
20. Gennari, L., Merlotti, D., Valenti, R., Ceccarelli, E., Ruvio, M., Pietrini, M. G., et al. (2012). Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J. Clin. Endocrinol. Metab. 97, 1737-1744. doi:10.1210/jc.2011-2958
21. Hanson, D. A., and Eyre, D. R. (1996). Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J. Biol. Chem. 271, 26508- 26516. doi:10.1074/jbc.271.43.26508
22. Hong, H. H., Uzel, M. I., Duan, C., Sheff, M. C., and Trackman, P. C. (1999). Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab. Invest. 79, 1655-1667.
23. Kang, H. A., and Trelstad, R. L. (1973). A collagen defect in homocystinuria. J. Clin. Invest. 52, 2571-2578. doi:10.1172/JCI107449
24. Karim, L., Tang, S. Y., Sroga, G. E., and Vashishth, D. (2013). Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone. Osteoporos. Int. doi:10.1007/s00198-013-2319-4 [Epub ahead of print].
25. Kim, J. Y., Lee, S. K., and Jo, K. J. (2013). Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes. Life. Sci. 92, 533-540. doi:10.1016/j.lfs.2013.01.001
26. Knott, L., and Bailey, A. J. (1998). Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone 22, 181-187. doi:10.1016/S8756-3282(97)00279-2
27. Kuboki, Y., Kudo, A., Mizuno, M., and Kawamura, M. (1992). Time-dependent changes of collagen cross-links and their precursors in the culture of osteogenic cells. Calcif. Tissue Int. 50, 473-480. doi:10.1007/BF00296780
28. Kuypers, R., Tyler, M., Kurth, L. B., Jenkins, I. D., and Horgan, D. J. (1992). Identification of the loci of the collagen-associated Ehrlich chromogen in type I collagen confirms its role as a trivalent cross-link. Biochem. J. 283, 129-136.
29. Leslie, W. D., Rubin, M. R., Schwartz, A. V., and Kanis, J. A. (2012). Type 2 diabetes and bone. J. Bone Miner. Res. 27, 2231-2237. doi:10.1002/jbmr.1759
30. Li, G., Xu, J., and Li, Z. (2012). Receptor for advanced glycation end products inhibits proliferation in osteoblast through suppression of Wnt, PI3K and ERK signaling. Biochem. Biophys. Res. Commun. 423, 684-689. doi:10.1016/j.bbrc.2012.06.015
31. Liu, G., Nellaiappan, K., and Kagan, H. M. (1997). Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J. Biol. Chem. 272, 32370-32377. doi:10.1074/jbc.272.51.32370
32. Manolagas, S. C., and Almeida, M. (2007). Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol. Endocrinol. 21, 2605-2614. doi:10.1210/me.2007-0259
33. McLean, R. R., and Hannan, M. T. (2007). B vitamins, homocysteine, and bone disease: epidemiology and pathophysiology. Curr. Osteoporos. Rep. 5, 112-119. doi:10.1007/s11914-007-0026-9
34. Mercer, N., Ahmed, H., Etcheverry, S. B., Vasta, G. R., and Cortizo, A. M. (2007). Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells. Mol. Cell. Biochem. 306, 87-94. doi:10.1007/s11010-007-9557-8
35. Mitome, J., Yamamoto, H., Saito, M., Yokoyama, K., Marumo, K., and Hosoya, T. (2011). Non-enzymatic crosslinking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients. Calcif. Tissue Int. 88, 521-529. doi:10.1007/s00223-011-9488-y
36. Miyata, T., Notoya, K., Yoshida, K., Horie, K., Maeda, K., Kurokawa, K., et al. (1997). Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J. Am. Soc. Nephrol. 8, 260-270.
37. Monnier, V. M., Sell, D. R., Dai, Z., Nemet, I., Collard, F., and Zhang, J. (2008). The role of the amadori product in the complications of diabetes. Ann. N. Y. Acad. Sci. 1126, 81-88. doi:10.1196/annals.1433.052
38. Nakamura, K., Nakazawa, Y., and Ienaga, K. (1997). Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. Biochem. Biophys. Res. Commun. 232, 227-230. doi:10.1006/bbrc.1997.6262
39. Ogawa, N., Yamaguchi, T., Yano, S., Yamauchi, M., Yamamoto, M., and Sugimoto, T. (2007). The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs. Horm. Metab. Res. 39, 871-875. doi:10.1055/s-2007-991157
40. Okazaki, K., Yamaguchi, T., Tanaka, K., Notsu, M., Ogawa, N., Yano, S., et al. (2012). Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis. Calcif. Tissue Int. 91, 286-296. doi:10.1007/s00223-012-9641-2
41. Okazaki, R., Totsuka, Y., Hamano, K., Ajima, M., Miura, M., Hirota, Y., et al. (1997). Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J. Clin. Endocrinol. Metab. 82, 2915-2920. doi:10.1210/jc.82.9.2915
42. Opsahl, W., Zeronian, H., Ellison, M., Lewis, D., Rucker, R. B., and Riggins, R. S. (1982). Role of copper in collagen cross-linking and its influence on selected mechanical properties of chick bone and tendon. J. Nutr. 112, 708-716.
43. Oxlund, H., Barckman, M., Ortoft, G., and Andreassen, T. T. (1995). Reduced concentrations of collagen cross-links are associated with reduced strength of bone. Bone 17, 365S-371S. doi:10.1016/8756-3282(95)98420-R
44. Ozasa, H., Tominaga, T., Nishimura, T., and Takeda, T. (1981). Lysyl oxidase activity in the mouse uterine cervix is physiologically regulated by estrogen. Endocrinology 109, 618-621. doi:10.1210/endo-109-2-618
45. Poundarik, A. A., Diab, T., Sroga, G. E., Ural, A., Boskey, A. L., Gundberg, C. M., et al. (2012). Dilatational band formation in bone. Proc. Natl. Acad. Sci. U.S.A. 109, 19178-19183. doi:10.1073/pnas.1201513109
46. Raposo, B., Rodríguez, C., Martínez-González, J., and Badimon, L. (2004). High levels of homocysteine inhibit lysyl oxidase (LOX) and down regulate LOX expression in vascular endothelial cells. Atherosclerosis 177, 1-8. doi:10.1016/j.atherosclerosis.2004.06.015
47. Reiser, K., Summers, P., Medrano, J. F., Rucker, R., Last, J., and McDonald, R. (1996). Effects of elevated circulating IGF-1 on the extracellular matrix in highgrowth C57BL/6J mice. Am. J. Physiol. 271, R696-R703.
48. Robins, S. P., and Bailey, A. J. (1972). Age-related changes in collagen: the identification of reducible lysine-carbohydrate condensation products. Biochem. Biophys. Res. Commun. 48, 76-84. doi:10.1016/0006-291X(72)90346-4
49. Robins, S. P., and Bailey, A. J. (1977). The chemistry of the collagen cross-links. Characterization of the products of reduction of skin, tendon and bone with sodium cyanoborohydride. Biochem. J. 163, 339-346.
50. Rodríguez, C., Alcudia, J. F., Martínez-González, J., Raposo, B., Navarro, M. A., and Badimon, L. (2008). Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction. Atherosclerosis 196, 558-564. doi:10.1016/j.atherosclerosis.2007.06.002
51. Saito, M., Fujii, K., and Marumo, K. (2006a). Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif. Tissue Int. 79, 160-168. doi:10.1007/s00223-006-0035-1
52. Saito, M., Fujii, K., Soshi, S., and Tanaka, T. (2006b). Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos. Int. 17, 986-995. doi:10.1007/s00198-006-0087-0
53. Saito, M., Fujii, K., Mori, Y., and Marumo, K. (2006c). Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos. Int. 17, 1514-1523. doi:10.1007/s00198-006-0155-5
54. Saito, M., Marumo, K., Fujii, K., and Ishioka, N. (1997). Single column high - performance liquid chromatographic - fluorescence detection of immature, mature and senescent cross-links of collagen. Anal. Biochem. 253, 26-32. doi:10.1006/abio.1997.2350
55. Saito, M., Marumo, K., Kida, Y., Ushiku, C., Kato, S., Takao-Kawabata, R., et al. (2011a). Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys. Osteoporos. Int. 22, 2373-2383. doi:10.1007/s00198-010-1454-4
56. Saito, M., Marumo, K., Ushiku, C., Kato, S., Sakai, S., Hayakawa, N., et al. (2011b). Effects of alfacalcidol on mechanical properties and collagen cross-links of the femoral diaphysis in glucocorticoid-treated rats. Calcif. Tissue Int. 88, 314-324. doi:10.1007/s00223-011-9472-6
57. Saito, M., Marumo, K., Kida, Y., Ushiku, C., Kato, S., Takao-Kawabata, R., et al. (2011c). Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys. Osteoporos. Int. 22, 2373-2383. doi:10.1007/s00198-010-1454-4
58. Saito, M., Marumo, K., Soshi, S., Kida, Y., Ushiku, C., and Shinohara, A. (2010a). Raloxifene ameliorates detrimental enzymatic and non-enzymatic collagen crosslinks and bone strength in rabbits with hyperhomocysteinemia. Osteoporos. Int. 21, 655-666. doi:10.1007/s00198-009-0980-4
59. Saito, M., Shiraishi, A., Ito, M., Sakai, S., Hayakawa, N., Mihara, M., et al. (2010b). Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model. Bone 46, 1170-1179. doi:10.1016/j.bone.2009.12.008
60. Saito, M., Mori, S., Mashiba, T., Komatsubara, S., and Marumo, K. (2008). Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs. Osteoporos. Int. 19, 1343-1354. doi:10.1007/s00198-008-0585-3
61. Saito, M., Soshi, S., and Fujii, K. (2003). Effect of hyper- and microgravity on collagen post-translational controls of MC3T3-E1 osteoblasts. J. Bone Miner. Res. 18, 1695-1705. doi:10.1359/jbmr.2003.18.9.1695
62. Saito, M., Soshi, S., Tanaka, T., and Fujii, K. (2004a). Intensity-related differences in collagen post-translational modification in MC3T3-E1 osteoblasts after exposure to low and high intensity pulsed ultrasound. Bone 35, 644-655. doi:10.1016/j.bone.2004.04.024
63. Saito, M., Fujii, K., Tanaka, T., and Soshi, S. (2004b). Effect of low- and high-intensity pulsed ultrasound on collagen post-translational modifications in MC3T3-E1 osteoblasts. Calcif. Tissue Int. 75, 384-395. doi:10.1007/s00223-004-0292-9
64. Sanada, H., Shikata, J., Hamamoto, H., Ueba, Y., Yamamuro, T., and Takeda, T. (1978). Changes in collagen cross-linking and lysyl oxidase by estrogen. Biochim. Biophys. Acta 541, 408-413. doi:10.1016/0304-4165(78)90199-X
65. Sanguineti, R., Storace, D., Monacelli, F., Federici, A., and Odetti, P. (2008). Pentosidine effects on human osteoblasts in vitro. Ann. N. Y. Acad. Sci. 1126, 166-172. doi:10.1196/annals.1433.044
66. Satio, M. (1999). Age-related changes in biochemical characteristics of collagen from human weight-bearing and non-weight-bearing bone. Tokyo Jikeikai Med. J. 114, 327-337. (in Japanese).
67. Satio, M., Fujii, K., and Shoshi, S. (2005). Effects of vitamin B6 and vitamin K2 on bone mechanical properties and collagen cross-links in spontaneously diabetic WBN/Kob rats. J. Bone Miner. Res. 20(Suppl. S1), abstr. SU420.
68. Satio, M., and Marumo, K. (2010). Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos. Int. 21, 195-214. doi:10.1007/s00198-009-1066-z
69. Schwartz, A. V., Vittinghoff, E., Bauer, D. C., Hillier, T. A., Strotmeyer, E. S., Ensrud, K. E., et al. (2011). Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305, 2184-2192. doi:10.1001/jama.2011.715
70. Seeman, E., and Delmas, P. D. (2006). Bone quality - the material and structural basis of bone strength and fragility. N. Engl. J. Med. 354, 2250-2261. doi:10.1056/NEJMra053077
71. Sell, D. R., Biemel, K. M., Reihl, O., Lederer, M. O., Strauch, C. M., and Monnier, V. M. (2005). Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J. Biol. Chem. 280, 12310-12315. doi:10.1074/jbc.M500733200
72. Silva, M. J., Brodt, M. D., Lynch, M. A., McKenzie, J. A., Tanouye, K. M., Nyman, J. S., et al. (2009). Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J. Bone Miner. Res. 24, 1618-1627. doi:10.1359/jbmr.090316
73. Sims, T. J., Rasmussen, L. M., Oxlund, H., and Bailey, A. J. (1996). The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 39, 946-951. doi:10.1007/BF00403914
74. Starup-Linde, J. (2013). Diabetes, biochemical markers of bone turnover, diabetes control, and bone. Front. Endocrinol. (Lausanne) 4:21. doi:10.3389/fendo.2013.00021
75. Sugiyama, S., Miyata, T., Ueda, Y., Tanaka, H., Maeda, K., Kawashima, S., et al. (1998). Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J. Am. Soc. Nephrol. 9, 1681-1688.
76. Takahashi, M., Ohishi, T., Aoshima, H., Kawana, K., Kushida, K., Inoue, T., et al. (1993). The Maillard protein cross-link pentosidine in urine from diabetic patients. Diabetologia 36, 664-667. doi:10.1007/BF00404078
77. Tanaka, S., Narusawa, K., Onishi, H., Miura, M., Hijioka, A., Kanazawa, Y., et al. (2011). Lower osteocalcin and osteopontin contents of the femoral head in hip fracture patients than osteoarthritis patients. Osteoporos. Int. 22, 587-597. doi:10.1007/s00198-010-1328-9
78. Tang, S. Y., Zeenath, U., and Vashishth, D. (2007). Effects of non-enzymatic glycation on cancellous bone fragility. Bone 40, 1144-1151. doi:10.1016/j.bone.2006.12.056
79. Tomasek, J. J., Meyers, S. W., Basinger, J. B., Green, D. T., and Shew, R. L. (1994). Diabetic and age-related enhancement of collagen-linked fluorescence in cortical bones of rats. Life Sci. 55, 855-861. doi:10.1016/0024-3205(94)90041-8
80. Turecek, C., Fratzl-Zelman, N., Rumpler, M., Buchinger, B., Spitzer, S., Zoehrer, R., et al. (2008). Collagen cross-linking influences osteoblastic differentiation. Calcif. Tissue Int. 82, 392-400. doi:10.1007/s00223-008-9136-3
81. Uzawa, K., Grzesik, W. J., Nishiura, T., Kuznetsov, S. A., Robey, P. G., Brenner, D. A., et al. (1999). Differential expression of human lysyl hydroxylase genes, lysine hydroxylation, and cross-linking of type I collagen during osteoblastic differentiation in vitro. J. Bone Miner. Res. 14, 1272-1280. doi:10.1359/jbmr.1999.14.8.1272
82. Valcourt, U., Merle, B., Gineyts, E., Viguet-Carrin, S., Delmas, P. D., and Garnero, P. (2007). Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J. Biol. Chem. 282, 5691-5703. doi:10.1074/jbc.M610536200
83. Vashishth, D. (2007). The role of the collagen matrix in skeletal fragility. Curr. Osteoporos. Rep. 5, 62-66. doi:10.1007/s11914-007-0004-2
84. Vashishth, D., Gibson, G. J., Khoury, J. I., Schaffler, M. B., Kimura, J., and Fyhrie, D. P. (2001). Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28, 195-201. doi:10.1016/S8756-3282(00)00434-8
85. Vestergaard, P. (2007). Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos. Int. 18, 427- 444. doi:10.1007/s00198-006-0253-4
86. Viguet-Carrin, S., Farlay, D., Bala, Y., Munoz, F., Bouxsein, M. L., and Delmas, P. D. (2008). An in vitro model to test the contribution of advanced glycation end products to bone biomechanical properties. Bone 42, 139-149. doi:10.1016/j.bone.2007.08.046
87. Viguet-Carrin, S., Gineyts, E., Bertholon, C., and Delmas, P. D. (2009). Simple and sensitive method for quantification of fluorescent enzymatic mature and senescent crosslinks of collagen in bone hydrolysate using single-column high performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 1-7. doi:10.1016/j.jchromb.2008.10.043
88. Wang, S. X., Mure, M., Medzihradszky, K. F., Burlingame, A. L., Brown, D. E., Dooley, D. M., et al. (1996). A crosslinked cofactor in lysyl oxidase: redox function for amino acid side chains. Science 273, 1078-1084. doi:10.1126/science.273.5278.1078
89. Wang, X., and Qian, C. (2006). Prediction of microdamage formation using a mineral-collagen composite model of bone. J. Biomech. 39, 595-602. doi:10.1016/j.jbiomech.2005.01.009
90. Wang, X., Shen, X., Li, X., and Agrawal, C. M. (2002). Age-related changes in the collagen network and toughness of bone. Bone 31, 1-7. doi:10.1016/S8756-3282 (01)00697-4
91. Yamamoto, M., Yamaguchi, T., Yamauchi, M., and Sugimoto, T. (2009a). Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes. Diabetes Care 32, 2263-2268. doi:10.2337/dc09-0901
92. Yamamoto, M., Yamaguchi, T., Yamauchi, M., Kaji, H., and Sugimoto, T. (2009b). Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J. Bone Miner. Res. 24, 702-709. doi:10.1359/jbmr.081207
93. Yamamoto, M., Yamaguchi, T., Yamauchi, M., Yano, S., and Sugimoto, T. (2008). Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J. Clin. Endocrinol. Metab. 93, 1013-1019. doi:10.1210/jc.2007-1270
94. Yamauchi, M., and Katz, E. P. (1993). The post-translational chemistry and molecular packing of mineralizing tendon collagens. Connect. Tissue Res. 29, 81-98. doi:10.3109/03008209309014236
95. Yang, J., Hu, X., Zhang, Q., Cao, H., Wang, J., and Liu, B. (2012). Homocysteine level and risk of fracture: a meta-analysis and systematic review. Bone 51, 376-382. doi:10.1016/j.bone.2012.05.024
96. Zhou, Z., Han, J. Y., Xi, C. X., Xie, J. X., Feng, X., Wang, C. Y., et al. (2008). HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE. J. Bone Miner. Res. 23, 1084-1096. doi:10.1359/jbmr.080234